WOUND HEALING POTENCY OF ETHANOLIC EXTRACT OF LEUCAS URTICIFOLIA IN EXPERIMENTAL ANIMALS
HTML Full TextWOUND HEALING POTENCY OF ETHANOLIC EXTRACT OF LEUCAS URTICIFOLIA IN EXPERIMENTAL ANIMALS
Sushil Suthar*1 and Ritesh Patel 2
CMJ University 1, Shillong-793 003, Meghalya, India
Department of Pharmaceutics, S. K. Patel College of Pharmaceutical Education & Research, Ganpat University 2, Mehsana, Gujarat, India
ABSTRACT
The present study was planned to investigate the effect of ethanolic extract of Leucas Urticifolia on resutured incision, excision and burn wounds in Wistar rats. Resutured incision, excision and dead space wounds were inflicted under light ether anaesthesia aseptically. In incision wound model the control animals receive only distilled water and all test animals were treated with different doses of Lucas urticifolia ethanolic extract (100, 200 and 400 mg/kg), orally for a period of 10 days. On the day 11, wound breaking strength of the resutured incision wound was estimated. In excision and burn wound models the animals were treated topically daily with two different concentrations (5% and 10%w/w) of extracts and the rats of standard groups were treated with 5% povidone iodine ointment topically till the complete closure. The percentage wound contraction and epithelization period were studied from day of creating wound till complete closure of the wound. The ethanolic extract of L. urticifolia show significant wound healing activity against all wound models studies. High wound breaking strength, high rate of wound contraction and decrease in period of epithelialisation were observed in treated animals when compared to control group of animals. From the results obtained it can be concluded that ethanolic extract of L. urticifolia has significant wound healing activity. The enhanced wound healing activity of ethanolic extract may be due to free radical scavenging action and the antibacterial property of the phytoconstituents (flavonoids) present in it which either due to their individual or additive effect fastens the process of wound healing.
Keywords:
Leucas urticifolia, Wound Healing activity, Incision wound, Excision wound, Burn wound, |
Collagen
INTRODUCTION: Wound may be defined as a loss or breaking of cellular and anatomic or functional continuity of living tissue 1. Wound healing is a process by which a damaged tissue is restored as closely as possible to its normal state and wound contraction is the process of shrinkage of area of the wound 2. Three different phases constitute the physiologic process of wound-healing;
(i) substrate phase,
(ii) proliferative phase and
(iii) remodeling phase.
All these steps are orchestrated in controlled manner by a variety of cytokines including growth factors. Some of these growth factors like platelet derived growth factor, transforming growth factor B, fibroblast growth factor and epidermal growth factor etc. have been identified in self healing wounds.
In chronic wounds the application of some growth promoting agents or some compounds which can enhance the in situ generation of these growth factors is required to augment the healing process 3. Today wound healing abnormalities are among the greatest causes of disability and deformity. "I dressed the wound, God healed it" wound healing involves multiple complicated events 4.
The understanding of the mechanism of wound healing has increased dramatically during last few years. Herbs have been used as a source of drugs to combat diseases since time immemorial. The effectiveness, easy availability, low cost and non-toxic nature of herbal remedies are main reasons for its popularization. Ayurveda describes several drugs of plant, mineral, and animal origin for their wound healing properties under the term Vranaropaka. Most of these drugs are derived from plant origin.5
Leucas Urticifolia belong to family Lamiaceae is an annual herb distributed in the Rajasthan, Punjab, Baluchistan, Sindh and Rajputana desert of Pakistan 6, 7. It is commonly known as kubo in gujrati 8,darkan in rajasthani 6, it is also known as Goma or Guldora 7. The plant is tarditionaly also used for the treatment of diarrhea, dysentery, uterine haemorrhages, dropsy, gravel, cystitis, calculus, bronchial catarrh, skin diseases, fever and various types of mental disorders. The decoction of the leaves and apical shoots with gur is used locally as an abortifacient up to 3 months of pregnancy 9.
Leucas urticifolia is reported to have Triterpenes like: Leucisterol, β-sitosterol, and ursolic acid 10, Diterpene: Momilactone-A 11, Flavonoids: Leufolins A, Leufolins B 12, Acids and esters: Urticic acid, Methoxybenzyl benzoate, 4-hydroxy benzoic acid 10.
The flavonoidal glucosides leufolins A and B of Leucas Urticaefolia exhiited significant inhibitory potential against the enzyme butyrylcholinesterase 12.
A survey of literature revealed that no systematic approach has been made to study wound healing activity of this plant. Hence, the present study was undertaken to evaluate wound healing potency of ethanolic extract of Leucas urticifolia on various animal wound models in Wistar rats.
MATERIALS AND METHODS:
Plant material: The leaves of Leucas urticifolia were dried in shade and powdered coarsely. For preparation of ethanolic extract, Coarse powder of the leaves was successively extracted in soxhlet apparatus using petroleum ether at 60-80oC followed by 90% ethanol and that concentrated under reduced pressure to yield concentrated ethanol extract. The dried extract was stored at 4°C until used. The extract was subjected to preliminary phytochemical tests.
Preliminary phytochemical studies: The ethanolic extract of Leucas urticifolia subjected to qualitative chemical investigation for the identification of the phytoconstituents- sterols, glycosides, saponins, carbohydrates, alkaloids, flavonoids, tannins, proteins 13.
Drug formulations: For topical application ointment of the extract was prepared using 2% sodium alginate as ethanolic base containing 5% w/w and 10% w/w of drug extracts. All the preparations to be given by oral route were prepared freshly in distilled water just before dosing.
Animals: Healthy Wistar albino rats of either sex and of approximately same age (12 to13 weeks), weighing between 180-200 g were used for the study. The animals were acclimatized by keeping them in animal house facility of Sri Balaji College of Pharmacy, Jaipur, Rajasthan. They were housed individually in polypropylene (32x24x16 cm) cages containing bedding material as husk and maintained under controlled conditions of temperature (23±2oC), humidity (55±5%) and 12 h light and 12 h dark cycles, and were fed with commercial pellet rat chow and water ad libitum.
The norms for Good Laboratory Practice were followed for care of laboratory animals. The studies were conducted after obtaining the approval from Institutional Animal Ethical Committee clearance of Sri Balaji College of Pharmacy, Jaipur, Rajasthan. The animal house facility of this division is approved by Govt. of India under the Ministry of Environment and Forest (Reg no. 1212/ac/08/CPCSEA). The experimental protocol was approved by Institutional Animal Ethical Committee (IAEC) of Name of College and Place (Letter No. SBCP/IAEC/10-465) with CPCSEA Reg. no. 1212/ac/08/CPCSEA).
Acute Oral Toxicity Study: Acute oral toxicity study for the Leucas urticifolia ethanolic extract (LUEE) was carried out using OCED guideline 425 (modified, adopted 23rd march 2006) 14.
Skin Irritation Study: This study was carried out on rabbits. The skin of the animal was shaved at three different positions on the dorsal side, each about 500 mm2. The 1st area was kept as control, to which vehicle was applied. 2nd area was applied with LUAE (5%) and the 3rd area treated with LUAE (10%). After 4 hr, the skin was observed for signs of inflammation 15.
Incision Wound Model: In incision wound model, 6 cm long paravertebral incisions were made through the full thickness of the skin on either side of the vertebral column of the rat under the ether anaesthesia. The wounds were closed with interrupted sutures of 1 cm apart. The animals were divided into four groups of six animals each (Table 1). The animals of control group left untreated and animals of other groups were treated with 100, 200 and 400 mg/kg of LUEE respectively. The sutures were removed on the 8th post wound day and wound breaking strength was measured on 11th day of post wounding by continuous water flow technique. Three readings were taken on each wound and the mean of six such readings in each animal was used for statistical analysis. Subsequently animals were sacrificed by overdose of anaesthesia 16, 17.
Excision Wound Model: The animals were randomly divided into four groups of six animals each as shown in Table 2. The animals of control group left untreated, animals of other groups treated with standard 5%-povidine iodine, LUEE-5% and LUEE-10% ointment. A full thickness excision wound was created for this study according to Morton and Malone. The excision wound was created in overnight fasted animals under light ether anesthesia. A round circular seal of 500 mm2 diameter was impressed on the dorsal thoracic central region 5 cm away from the ears of anaesthetized rats. Full thickness skin from demarked area was excised to get a wound of approximate 500 mm2 area 18.
After achieving the full haemostasis, wound was blotted with cotton swab soaked in warm saline and animals were placed in individual cages.
Assessment of wound healing: All the animals were inspected daily and healing was assessed based on physical parameters namely wound contraction and complete epithelization period.
- Wound contraction: It was calculated by observing progressive change in wound area planimetrically. The contraction mainly contributes for wound closure and was studied by tracing the raw wound area on butter paper on day 2, 6, 10, 14 and 18th postoperative days or till complete wound healing, whichever occurred earlier. These wound tracings were taken on 1 mm2 graph paper to assess wound area and then wound contraction was calculated as percentage of original wound size for each animal in all the groups. Change in wound area was also calculated to indicate the rate of contraction.
% of wound contraction=
Initial wound size – Specific day wound size X 100
Initial wound size
- Epithelization period: It was monitored by noting the number of days required for the eschar to fall off from the burn wound surface without leaving a raw wound behind. The healed scar on day of epithelization was excised and used for determination of collagen content.19
Burn Wound Model: The animals were randomly divided into seven groups of six animals in each group as shown in Table 3. Partial thickness burn wound was created on overnight starved animals under light ether anesthesia, by pouring hot molten wax at 80oC into a metal cylinder of 300 mm2. The back of the animal just below the neck was shaved just before creating the wound. The molten wax in the cylinder was allowed to solidify which took about 10-12 minutes. Then the metal cylinder with wax adhered to the skin was removed which left a distinctly demarked partial thickness circular burn wound of 300 mm2 area 19, 20. After animals recovered completely from anesthesia, they were kept in individual cages.
All the animals were inspected daily and healing was assessed based on physical parameters namely wound contraction and complete epithelization period as described above.
Statistical analysis: Results are expressed as mean ± S.D. Statistical differences between means were determined by One-way ANOVA followed by Tukey’s post hoc test using GraphPad Prism 5. P value <0.05 was considered significant.
RESULTS:
Phytochemical screening: The phytochemical tests revealed that the ethanolic extract of Leucas urticifolia leaves possess alkaloids, flavonoids, tannins, glycosides, carbohydrates and proteins in ethanolic extracts.
Acute toxicity study: The ethanolic extract of Leucas Urticifolia was found to be safe upto dose of 2000 mg/kg b.w. without produce any mortality and other toxic effects. Hence the 1/20th, 1/10th, and 1/5th of doses was taken, which were found to be 100, 200 and 400 mg/kg body weight.
Skin irritation study: LUAE (5%, and 10% ointment) did not show any irritation and there was no evidence of any noticeable inflammation and redness.
Resutured incision wound healing: The results of Incision wound healing activity are shown in Table 1. In incision wound model all the three doses viz. LUEE-100, LUEE-200 and LUEE-400 mg/kg treated animals showed significant (P<0.001) increase in wound breaking strength (249.50±7.63), (308.50±17.61) and (350.50±15.47) respectively when compared to the control group (197.00±9.75).
*** |
TABLE 1: EFFECT OF LEUCAS URTICIFOLIA ETHANOLIC EXTRACTS ORALLY ON INCISION WOUND HEALING
Groups | Control | LUEE-100 | LUEE-200 | LUEE-400 |
Wound breaking strength (g) | 197.00±9.75 | 249.50±7.63*** | 308.50±17.61*** | 350.50±15.47*** |
Values are expressed as mean ± SD on six animals in each group; ‘***’ P<0.001 when compared to control group.
Excision wound healing: The results of excision wound model are given in Table 2. In excision wound model, the mean percentage wound closure was calculated on the 2, 6, 10, 14 and 18 post wounding days. The rate of wound closure in LUEE treated animals is significant (P<0.001) more on 10, 14 and 18th day as compared to that of control group. LUEE-5% and LUEE-10% also significantly (P<0.001) reduced the epithelization time from 21.83±0.98 to 13.50±1.04and 13.16±1.32 days, when compared with control. The standard povidone iodine showed significant effect, i.e. p < 0.001 as compared with control. The wound healing potency of LUEE-5% and LUEE-10% ointment, found to be statistically similar to the standard povidone iodine-5% ointment.
The collagen content in healed scar of the control group was 41.83 mg/g of tissue. The application of povidone iodine ointment and LUAE ointment caused a significant (P<0.001) increase in collagen content of the scar tissue.
TABLE 2. EFFECT OF TOPICAL APPLICATION OF ETHANOLIC EXTRACT OF LEUCAS URTICIFOLIA ON HEALING OF EXCISION WOUND IN WISTAR ALBINO RATS
Groups | Wound area (mm) on different days | Epithelization
period (Days) |
Collagen content
(mg/g) |
||||
Day-2 | Day-6 | Day-10 | Day-14 | Day-18 | |||
Control | 349.00±21.03
(32.20±4.20) |
239.00±12.18
(52.20±2.43) |
198.00±11.55
(60.40±2.31) |
143.33±10.44
(71.30±2.08) |
46.83±7.54
(90.63±1.50) |
21.83±0.98 | 41.83±2.31 |
Standard | 364.16±17.13
(27.16±3.42) |
218.00±16.29
(56.4±3.25) |
25.16±3.81
(94.96±0.76)*** |
1.00±1.67
(99.80±0.33)*** |
-
(100±00)*** |
13.16±1.16*** | 58.33±1.87*** |
LUEE-5% | 359.16±23.31
(28.16±4.66) |
248.00±18.89
(50.4±3.77) |
100.83±10.51
(79.83±2.10)*** |
2.00±1.09
(99.60±0.21)***,ns |
(100±00)***,ns | 13.50±1.04***,ns | 48.33±2.87*** |
LUEE-10% | 352.50±24.35
(26.86±4.97) |
231.16±12.95
(50.73±3.23) |
53.16±9.90
(75.03±2.18)*** |
1.66±2.06
(85.40±3.63)***,ns |
(100±00)***,ns | 13.16±1.32***,ns | 58.33±2.25*** |
Values are expressed as mean ± SD on six animals in each group; values in paranthesis indicate percentage wound contraction; ‘***’ P<0.001 when compared to control group; ‘ns’ no significant when compared to standard group.
Burn Wound Healing: The results of burn wound model are given in table 3.In burn wound healing activity the period of epithelization was reduced significantly in povidone iodine (14.50 ± 2.07), LUEE-5% (18.16±1.83) and LUEE-10% (16.16±0.75) treated animals (P <0.001) when compared to the control group. LUEE-5% and 10 showed significant increase in percentage wound contraction on day 6, 10, 14 and 18th compared to the control group. The percentage wound contraction of LUEE-5% ointment is found to be statistically similar to the povidone iodine treated group on day 6 and 18. On the day 6, 14 and 18 the percentage wound contraction of LUEE-10% ointment treated group is statistically similar with standard povidone iodine treated group. The prohealing potency of LUEE-10% ointment is also found to be equipotent with standard povidone iodine-5% ointment.
TABLE 3. EFFECT OF TOPICAL APPLICATION OF ETHANOLIC EXTRACT OF LEUCAS URTICIFOLIA ON HEALING OF BURN WOUND IN WISTAR ALBINO RATS
Groups | Wound area (mm) on different days | Epithelization period (days) | ||||
Day-2 | Day-6 | Day-10 | Day-14 | Day-18 | ||
Control | 329.33±20.83
(5.97±5.94) |
226.66±17.18
(35.28±4.90) |
176.66±11.51
(49.56±3.28) |
102.66±8.09
(70.69±2.30) |
63.16±7.13
(81.96±2.03) |
25.33±1.21 |
Standard | 345.83±19.60
(1.26±5.59) |
165.66±15.13***
(52.70±4.32)*** |
58.00±7.72***
(83.44±2.20)*** |
10.83±11.90***
(96.90±3.30) |
(100±00)*** | 14.50±2.07*** |
LUEE-5% | 335.33±26.20
(4.26±7.48) |
180.00±8.36
(48.61±2.38)***,ns |
114.16±8.95
(67.40±2.55)*** |
53.00±27.87
(84.86±7.95) |
11.50±13.47
(96.71±3.84)***,ns |
18.16±1.83*** |
LUEE-10% | 346.00±19.70
(1.22±5.62) |
167.00±13.05
(52.32±3.72)***,ns |
101.83±8.15
(70.92±2.32)*** |
19.16±5.95
(94.52±1.69)***,ns |
(100±00)***,ns | 16.16±0.75***,ns |
Values are expressed as mean ± SD on six animals in each group; values in paranthesis indicate percentage wound contraction; ‘***’ P<0.001 when compared to control group; ‘ns’ no significant when compared to standard group.
DISCUSSION: The main objective of this study is to evaluate the influence LUAE on healing of excision, resutured incision and burn wounds in male Wistar rats. The findings of the present study clearly indicated that the LUAE treated groups significantly enhanced wound healing as assessed by wound breaking strength in resutured incision wound, wound closure rate, time taken for complete epithelisation in excision and burn wound models. The LUAE also tested for its influence on collagenation.
The LUAE ointment promote the healing in all three models by the influencing wound breaking strength, wound contraction, epithelization phase and collagenation. While the phase of collagenation give the required strength to the scars of wounds healed by primary and secondary intentions, wound contraction reduce the gap of open wound to be filled by extracellular matrix which is rich in collagen and finally covered by epithelium. Two principal component of collagenation phase are collagen synthesis and maturation. Based on the results of the study, it could be assumed that LUAE might have enhanced strength of scar by increasing the collagen levels, which could stitch the wound edge together at the repair site.
However a number of phases of healing, especially coagulation, inflammation, macrophagia, fibroplasias, collagenation, wound contraction and epithelialization etc. are intimately interlinked. Therefore the treatment could influence the healing of wound by intervening in any one or more phases of healing. Thus based on present study design, it is very difficult to comment on exact location and mechanism of the prohealing action of LUAE topical applications 21.
The excision wound healing model is often used for wound healing evaluation because it represents a true wound that could be reproducibly analyzed in nonsubjective, highly controlled manner 22, 23.
Phytochemical screening revealed the presence of tannins, flavonoids, alkaloids, proteins and other important constituents. Flavonoids have been documented 24 to possess potent antioxidant and free radical scavenging effect, which is believed to be one of the most important components of wound healing. Phytochemical screening revealed the presence of flavonoids in L. urticifolia. Thus, the enhanced wound healing may be due to free radical scavenging action and the antibacterial property of the phyto-constituents present in it which either due to their individual or additive effect fastens the process of wound healing. This could be the reason for prohealing activity of L. urticifolia. This enhanced wound contraction effect of L. urticifolia and epithelization could possibly be made use of clinically in healing of open wounds. However confirmation of this suggestion will need well designed clinical evaluation.
In conclusion, L. urticifolia promoted wound healing in all the three cutaneous wound models. This prohealing effect of L. urticifolia needs to be further investigated for exact mechanism and to identify the bioactive compounds responsible for prohealing action.
ACKNOWLEDGMENT: The authors are thankful to the Management of Sri Balaji college of Pharmacy, Jaipur, Rajasthan, India for providing necessary facilities to conduct the research work.
REFERENCES:
- Puratchikody C, Devi N and Nagalakshmi G: Wound healing activity of Cyperus rotundus linn. Indian Journal of Pharmaceutical Sciences 2006; 68:32-36.
- Singh SDJ, Krishna V, Mankani KL, Manjunatha BK, Vidya SM and Manohara YN: Wound healing activity of the leaf extracts and deoxyelephantopin isolated from Elephantopus scab. Indian Journal of Pharmacology 2005; 37:384-89.
- Rasik AM, Shukla A, Patnaik GK, Dhawan BN, Kulshrestha DK and Srivastava S: Wound healing activity of latex of Euphorbia Neriifolia Linn. Indian Journal of Pharmacology 1996; 28:125-29.
- Deodhar AK and Rana RE: Surgical physiology of wound healing: a review. Journal of Postgraduate Medicine 1997; 43:210-12.
- Saldanha CJ: Flora of Karnataka. Oxford & IBH Publishing Co: India, 2004; 90-99.
- Jain SC, Jain R and Singh R: Ethnobotanical survey of Sariska and Siliserh regions from Alwar district of Rajasthan, India. Ethnobotanical Leaflets 2009; 13:171-88.
- Akhtar K, Khan SB and Malik A: Phytochemistry and pharmacological aspects of Leucas urticifolia (vahl) Benth. Journal of Pharmaceutical Research and Health Care 2009; 2(2):197-203.
- Kiritikhar KR, and Basu BD: Indian Medicinal Plants. International Book Distributors, Dehradun, India, Edition 1, 2005.
- Jafri SMH: Flora of Karachi. The Book Corporation Karachi, Karachi, Pakistan, 1966.
- Fatima I, Ahmad I, Anis I, Malik A, Afza N, Iqbal L, and Latif M: New Butyrylcholinesterase Inhibitory Steroid and Peroxy Acid from Leucas urticifolia. Archives of Pharmacal Research. 2008; 31(8):999-1003.
- Habib RS, Jamshaid M, Tahir M N, Khana T J, and Khan I U: (4R,5R,6S,7R,8S,9R,10S,13S)-7,8b-Epoxymomilactone-A. Acta Crystallographica 2008; 64:892.
- Noor A T, Fatima I, Ahmad I, Malik A, Afza N, Iqbal L, Latif M and Khan S B: Leufolins A and B, Potent Butyrylcholinesterase-inhibiting Flavonoid Glucosides from Leucas urticifolia. Molecules 2007; 12:1447-54.
- Kokate CK: Practical Pharmacognosy- Techniques and Experiments. Nirali Prakashan, Pune, India, Edition 9, 2002, 149-53.
- “Guidance document on acute oral toxicity testing” Series on testing and assessment No. 24, Organisation for economic co-operation and development, OECD Environment, health and safety publications, Paris 2001 (www.oecd.org/ehs).
- Gfeller W, Kobel W and Seifert G: Overview of animal test methods from skin irritation. Food and Chemical Toxicology 1985; 23(2):165-68.
- Lee KH: Studies on mechanism of action of salicylates II. Retardation of wound healing by aspirin. Journal of Pharmaceutical Sciences 1968; 7:1042-43.
- Rao KS, Patil PA and Malur PR: Promotion of cutaneous wound healing by famotidine in Wistar rats. Indian Journal of Medical Research 2007; 125:149-54.
- Shetty S, Udupa S and Udupa L: Evaluation of antioxidant and wound healing effect of alcoholic and aqueous extract of Ocimum sanctum Linn. in rats. Evidence-based Complementary and Alternative Medicine 2008; 5(1):95-101.
- Woessner JF: The determination of hydroxyproline in tissue and protein sample containing small proportion of amino acids. Archives of Biochemistry and Biophysics 1991; 93:440-47.
- Srivastava P and Durgaprasad S: Burn wound healing property of Cocos nucifera: An appraisal. Indian Journal of Pharmacology 2008; 40:144-46.
- Jamadar MG, Bairy KL and Kulkarni DR: Vehicle assessment for wound healing profile. Indian Drugs 1990; 27:342-45.
- Babu G, Sanjeeva and Bairy KL: Effect of Tridax procumbens on burn wound healing. Indian drugs 2003; 40(8):488-91.
- Chithra P, Sajithalal BG and Gowri C: Influence of Aloe vera on collagen turnover in healing of dermal wounds in rats. Indian Journal of Experimental Biology 1988; 36:896-901.
- Srikanth D, Shenoy RR and Rao CM: The effect of topical (gel) Astemizole and Terfenadine on wound healing. Indian Journal of Pharmacology 2008; 40(4):170-4.
How to cite this article:
Suthar S. * and Patel R.: Wound healing potency of ethanolic extract of leucas urticifolia in experimental animals.Int J Pharm Sci Res, 2012; Vol. 3(9): 3219-3224.